A special case report poster session is planned for the 2018 AAAAI/WAO Joint Congress meeting.  This forum will provide the opportunity to share novel/challenging allergy/immunology patient care experiences with attendees at the 2018 AAAAI/WAO Joint Congress meeting. Cases must be submitted by 11:59pm CT on August 31, 2017 to be considered for programming.

First year FITs submitting a case report for the FIT Interesting Case Workshops should NOT use this form.  The submission form and deadline for the FIT Workshops will be posted at a later date.

PLEASE NOTE: Case reports submitted for programming in the Case Report Poster Session will not be considered for programming as abstracts at the 2018 AAAAI/WAO Joint Congress meeting and will not be published in the Journal of Allergy & Clinical Immunology.  Case reports presented at this poster session will be included on the WAO website.  For traditional abstract submission, please use the AAAAI online abstract submission site: http://annualmeeting.aaaai.org/.


Case Report Poster Session Submission Guidelines

Authors: An individual may be the first/primary author of only one case report poster at the 2018 AAAAI/WAO Joint Congress special Case Report Poster Session.  Co-authorship of additional case reports is permitted.

Keywords:  Each case report must be submitted with one keyword, chosen by the submitting author.  This information will be used to assist in the systematic review and organization of case reports for the poster session.

Case Report Withdrawals:  Withdrawals must be received in writing at the AAAAI executive office by November 29, 2017

To be considered for programming at the 2018 AAAAI/WAO Joint Congress meeting, case reports must meet the following criteria:

1. The case report must be written in English and the poster presented in English.  Please review the content of your case report for accuracy.  It is the responsibility of the submitting author to ensure accuracy of content.  Standard abbreviations may be employed in the text. Non-proprietary (generic) names of drugs are to be used.  Trade names are not allowed.

2. The case should include a unique observation and/or a "teachable moment" that would be of value to others in the allergy/immunology community. It should be described in approximately 400 words total.

3. Previously published case reports will not be considered.

4. The case presentation must be HIPAA compliant. If any case content, including images, is identifiable as relevant to a specific patient, patient consent to share the information must be secured and shared with AAAAI.

5. The author submitting the case must have been directly involved in the treatment of the patient scenario under discussion.

6. If the case is selected for programming, the submitting author will be expected to attend the poster session at the 2018 AAAAI/WAO Joint Congress meeting, March 2-5, 2018 in Orlando, FL.

7. Case report poster presenters will not receive reimbursement for travel expenses to attend the meeting.   There is no submission fee for case report poster session submissions.

8. Case reports will be graded by several reviewers on the following criteria: (1) Significance (novelty of the case/lessons learned/unique international perspective; (2) Methodology (clinical & treatment approaches); (3) Structure/Format (quality of overall written case report).